Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA STRIDES PHARMA SCIENCE AUROBINDO PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 12.9 -49.8 - View Chart
P/BV x 1.1 1.3 83.5% View Chart
Dividend Yield % 1.9 0.0 -  

Financials

 AUROBINDO PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
STRIDES PHARMA SCIENCE
Mar-22
AUROBINDO PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs1,064947 112.4%   
Low Rs584305 191.9%   
Sales per share (Unadj.) Rs400.3341.9 117.1%  
Earnings per share (Unadj.) Rs45.7-40.5 -112.9%  
Cash flow per share (Unadj.) Rs64.9-14.5 -447.1%  
Dividends per share (Unadj.) Rs9.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs419.4262.5 159.8%  
Shares outstanding (eoy) m585.9489.79 652.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.11.8 112.5%   
Avg P/E ratio x18.0-15.5 -116.6%  
P/CF ratio (eoy) x12.7-43.1 -29.5%  
Price / Book Value ratio x2.02.4 82.4%  
Dividend payout %19.70-   
Avg Mkt Cap Rs m482,79956,177 859.4%   
No. of employees `000NANA-   
Total wages/salary Rs m34,5096,469 533.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,55530,703 764.0%  
Other income Rs m3,2261,320 244.4%   
Total revenues Rs m237,78132,022 742.5%   
Gross profit Rs m42,566-2,639 -1,612.8%  
Depreciation Rs m11,2652,330 483.5%   
Interest Rs m4861,767 27.5%   
Profit before tax Rs m34,040-5,417 -628.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,256-1,783 -407.1%   
Profit after tax Rs m26,784-3,634 -737.0%  
Gross profit margin %18.1-8.6 -211.1%  
Effective tax rate %21.332.9 64.8%   
Net profit margin %11.4-11.8 -96.5%  
BALANCE SHEET DATA
Current assets Rs m181,22733,618 539.1%   
Current liabilities Rs m81,56034,117 239.1%   
Net working cap to sales %42.5-1.6 -2,617.4%  
Current ratio x2.21.0 225.5%  
Inventory Days Days2592 27.2%  
Debtors Days Days62144 43.5%  
Net fixed assets Rs m155,10433,989 456.3%   
Share capital Rs m586898 65.3%   
"Free" reserves Rs m245,17422,670 1,081.5%   
Net worth Rs m245,76023,568 1,042.8%   
Long term debt Rs m2,4928,356 29.8%   
Total assets Rs m336,33167,607 497.5%  
Interest coverage x71.0-2.1 -3,437.6%   
Debt to equity ratio x00.4 2.9%  
Sales to assets ratio x0.70.5 153.6%   
Return on assets %8.1-2.8 -293.6%  
Return on equity %10.9-15.4 -70.7%  
Return on capital %13.9-11.4 -121.7%  
Exports to sales %31.160.7 51.2%   
Imports to sales %11.90-   
Exports (fob) Rs m72,86218,639 390.9%   
Imports (cif) Rs m27,965NA-   
Fx inflow Rs m77,24519,390 398.4%   
Fx outflow Rs m31,524529 5,961.0%   
Net fx Rs m45,72118,861 242.4%   
CASH FLOW
From Operations Rs m50,165-2,578 -1,945.8%  
From Investments Rs m-32,116-1,187 2,704.9%  
From Financial Activity Rs m-29,6934,213 -704.8%  
Net Cashflow Rs m-11,674449 -2,600.2%  

Share Holding

Indian Promoters % 48.8 30.8 158.3%  
Foreign collaborators % 3.1 0.3 1,137.0%  
Indian inst/Mut Fund % 38.0 36.9 102.9%  
FIIs % 21.4 21.4 100.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 68.9 69.9%  
Shareholders   358,459 130,682 274.3%  
Pledged promoter(s) holding % 15.9 70.0 22.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs STRIDES PHARMA SCIENCE Share Price Performance

Period Aurobindo Pharma STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 0.25% 2.17% -0.10%
1-Month -15.66% 11.19% -1.99%
1-Year -30.20% -28.50% -5.62%
3-Year CAGR 1.45% -3.09% 20.96%
5-Year CAGR -6.95% -15.59% 11.47%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 31.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

STRIDES PHARMA SCIENCE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.